Chemoinformaics analysis of Methyl triacontanoate
| Molecular Weight | 466.835 | nRot | 28 |
| Heavy Atom Molecular Weight | 404.339 | nRig | 48 |
| Exact Molecular Weight | 466.475 | nRing | 0 |
| Solubility: LogS | -4.813 | nHRing | 0 |
| Solubility: LogP | 4.737 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 95 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 62 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 31 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 94.7152 |
| nHD | 0 | BPOL | 64.8028 |
| QED | 0.193 |
| Synth | 7.1 |
| Natural Product Likeliness | 1.657 |
| NR-PPAR-gamma | 0.08 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.999 |
| Pgp-sub | 0.944 |
| HIA | 0.547 |
| CACO-2 | -5.26 |
| MDCK | 0.0000244 |
| BBB | 0.487 |
| PPB | 0.910275 |
| VDSS | 1.904 |
| FU | 0.0613141 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.977 |
| CYP2c19-inh | 0.062 |
| CYP2c19-sub | 0.953 |
| CYP2c9-inh | 0.091 |
| CYP2c9-sub | 0.332 |
| CYP2d6-inh | 0.969 |
| CYP2d6-sub | 0.904 |
| CYP3a4-inh | 0.956 |
| CYP3a4-sub | 0.934 |
| CL | 3.607 |
| T12 | 0.001 |
| hERG | 0.91 |
| Ames | 0.057 |
| ROA | 0.997 |
| SkinSen | 0.008 |
| Carcinogencity | 0.822 |
| EI | 0.006 |
| Respiratory | 0.964 |
| NR-Aromatase | 0.28 |
| Antiviral | No |
| Prediction | 0.53608 |